Medicine and Dentistry
Patient
100%
B Lymphocyte Subpopulation
95%
Microarray
73%
Diffuse Large B-Cell Lymphoma
69%
Gene
68%
B Cell
65%
Phenotype
63%
Prognosis
63%
Inpatient
38%
Doxorubicin
37%
Randomized Controlled Trial
35%
Pain
35%
Cell Line
35%
Chemotherapeutic Agent
34%
Drug
34%
Overall Survival
32%
microRNA 34a
31%
Melphalan
31%
Tissues
31%
Juvenile Idiopathic Arthritis
31%
Cryopreservation
31%
Specimen
31%
Follicular Lymphoma
31%
Bone Marrow Biopsy
31%
Aspiration
31%
Bone Marrow
31%
Personalized Medicine
31%
Association
31%
Lymphocyte
31%
Multiple Myeloma
31%
Hematological Cancer
31%
Opiate Antagonist
31%
Acute Pancreatitis
31%
Placebo
31%
Amaurosis
31%
Clinical Trial
31%
Cells
25%
Researcher
25%
Lymphoma
22%
Resistance Index
21%
Enalapril Maleate
19%
Progression Free Survival
18%
Pancreatitis
17%
Rituximab
17%
Analysis
17%
Gene Expression
15%
Opiate
14%
Fluorescence Activated Cell Sorting
13%
Laboratory
12%
In Vitro
12%
Biochemistry, Genetics and Molecular Biology
B Lymphocyte Subpopulation
95%
B Cell
74%
Microarray
68%
Classification
67%
Phenotype
63%
Gene Expression Profiling
46%
Doxorubicin
37%
Accuracy
36%
Normal Human
34%
Gene Signature
31%
Cryopreservation
31%
Thawing
31%
Real-Time Polymerase Chain Reaction
31%
Association
31%
Sample
27%
RNA
21%
Gene Expression
15%
Fluorescence Activated Cell Sorting
13%
Processing
12%
Rituximab
12%
Centroblasts
11%
Centrocyte
11%
MicroRNA
9%
Experiment
6%
Overall Survival
6%
Cyclophosphamide
6%
Cancer Classification
6%